| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akari Therapeutics Plc | Director, 10%+ Owner | Ordinary Shares, par value $0.0001 per share | 7.61B | $9.13M | $0.00 | Nov 14, 2024 | Direct |
| Akari Therapeutics Plc | Director, 10%+ Owner | American Depositary Shares representing Ordinary Shares | 4.7M | $5.26M | $1.12 | Mar 20, 2025 | Direct |
| Akari Therapeutics Plc | Director, 10%+ Owner | Series A Warrants (Right to Buy) | 893K | $1M | $1.12 | Mar 6, 2025 | Direct |
| Akari Therapeutics Plc | Director, 10%+ Owner | Series B Warrants (Right to Buy) | 893K | $1M | $1.12 | Mar 6, 2025 | Direct |
| Akari Therapeutics Plc | Director, 10%+ Owner | Ordinary Shares, par value $0.0001 per share | 219M | $263K | $0.00 | Nov 14, 2024 | By Hannol Ventures LLC |
| Akari Therapeutics Plc | Director, 10%+ Owner | American Depositary Shares representing Ordinary Shares | 109K | $123K | $1.12 | Mar 20, 2025 | Hannol Ventures LLC |
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 30K | $55.7K | $2.08 | Jun 5, 2025 | Direct |
| Peak Bio, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $0.27 | Nov 14, 2024 | Direct |
| Peak Bio, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $0.27 | Nov 14, 2024 | Indirect |
| Akari Therapeutics Plc | Director, 10%+ Owner | Stock Option (Right to Buy) | 225K | Mar 20, 2025 | Direct | ||
| Peak Bio, Inc. | Director, 10%+ Owner | Convertible Notes | 0 | Nov 14, 2024 | Direct | ||
| Peak Bio, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 0 | Nov 14, 2024 | Direct | ||
| Peak Bio, Inc. | Director, 10%+ Owner | Warrant (Right to Purchase) | 0 | Nov 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
| AKTX | Akari Therapeutics Plc | Mar 20, 2025 | 2 | $0 | 4 | Mar 24, 2025 | Director, 10%+ Owner |
| AKTX | Akari Therapeutics Plc | Mar 6, 2025 | 3 | $3M | 4 | Mar 10, 2025 | Director, 10%+ Owner |
| AKTX | Akari Therapeutics Plc | Nov 14, 2024 | 0 | $0 | 3 | Nov 22, 2024 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Nov 14, 2024 | 7 | -$2.13M | 4 | Nov 18, 2024 | Director, 10%+ Owner |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| PKBO | Peak Bio, Inc. | Sep 21, 2023 | 1 | $0 | 4 | Sep 25, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Sep 19, 2023 | 2 | $0 | 4 | Sep 21, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Sep 15, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Sep 13, 2023 | 2 | $0 | 4 | Sep 15, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Sep 11, 2023 | 2 | $0 | 4 | Sep 13, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Aug 29, 2023 | 7 | $0 | 4/A | Sep 12, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Aug 14, 2023 | 2 | $350K | 4 | Aug 15, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Jul 20, 2023 | 2 | $275K | 4 | Jul 21, 2023 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Jun 23, 2023 | 2 | $400K | 4 | Jun 27, 2023 | Director, 10%+ Owner |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| PKBO | Peak Bio, Inc. | Apr 28, 2023 | 2 | $1.13M | 4 | May 2, 2023 | Director |
| PKBO | Peak Bio, Inc. | Nov 1, 2022 | 2 | $0 | 4 | Nov 3, 2022 | Director, 10%+ Owner |
| PKBO | Peak Bio, Inc. | Nov 1, 2022 | 0 | $0 | 3 | Nov 3, 2022 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| PLRX | PLIANT THERAPEUTICS, INC. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |